Brijal Desai, MD received a dual degree with a B.S. in Economics from The
Wharton School and a B.A. in Biological Basis of Behavior from the University
of Pennsylvania. He completed his medical degree at the University of
Pennsylvania and his Radiation Oncology Residency at Northwestern University
in Chicago where he served as Chief Resident.
Dr. Desai has penned numerous publications on radiation therapy including
proton therapy for recurrent brain tumors, brain metastases management,
and on the development of novel therapeutics for metastatic melanoma.
His research work during residency has led to several poster presentations
at the American Society for Therapeutic Radiology and Oncology, American
Radium Society, Radiological Society of North America, Society of Neuro-Oncology,
and the American Association for Cancer Research annual meetings.
Dr. Desai has extensive clinical experience using a myriad of radiation
oncology technologies including three-dimensional conformal radiation
therapy (3D-CRT), intensity modulated radiation therapy (IMRT), stereotactic
radiosurgery (SRS), stereotactic body radiation therapy (SBRT), high-dose
rate (HDR) and low-dose rate (LDR) brachytherapy, proton therapy, intraoperative
radiation therapy, hyperthermia, pediatric radiation oncology and total
body irradiation. He is a member of numerous medical organizations including
the American Society for Therapeutic Radiology and Oncology and the American
Society of Clinical Oncology.
His clinical practice focuses on treating tumors of the central nervous
system, head and neck cancers, lung cancers, and on treating patients
using CyberKnife robotic radiosurgery.